# US 2013/0252903 A1 · Compositions for reducing oxidative stress and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0252903 A1
- Document ID: US20130252903A1
- Status: Published application
- Kind: A1
- Application number: 13/891,439
- Filed: 2013-05-10
- Published: 2013-09-26
- Earliest claimed: 2007-11-19
- Assignees: Universitaetsklinikum Muenster
- Applicants: Universitaetsklinikum Muenster
- Inventors: Markus Boehm
- Web page: https://patentgrep.com/patent/US20130252903A1

## CPC

- A61K 8/64: Proteins; Peptides; Derivatives or degradation products thereof
- A61P 17/14: for baldness or alopecia
- A61P 17/18: Antioxidants, e.g. antiradicals (preparations for protection against sunlight A61Q17/00)
- A61P 39/06: Free radical scavengers or antioxidants
- A61Q 7/00: Preparations for affecting hair growth
- A61Q 19/08: Anti-ageing preparations
- C07K 5/0815: {with the first amino acid being basic}
- C07K 5/0819: {with the first amino acid being acidic}
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- A61K 2800/522: Antioxidants; Radical scavengers
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention relates to the use of one or more tripeptides selected from the group consisting of NLys-Pro-ValC, NLys-Pro-ThrC and NpGlu-His-ProC for the reduction of oxidative stress. The above tripeptides are particularly useful for the treatment of a disease or damage caused by oxidative stress; such as vitiligo, scleroderma, necrosis, or erythema; furthermore, a disease or damage of the hair, like premature hair loss or premature formation of grey hair. Furthermore the invention relates the cosmetic use of the above tripeptides, in particular against skin aging. Further the invention relates cosmetic compositions containing at least one of said tripeptides.

## Claims

### Claim 1

A method for suppressing oxidative stress in skin of a subject that becomes exposed to UV-A-containing light, comprising a step of
topically applying to skin of a patient a composition comprising at least one compound selected from the group consisting of
(a) NLys-Pro-ThrC and
(b) NpGlu-His-ProC
wherein the compound is present in an amount effective for the suppression of oxidative stress in response to UV-A-containing light.

### Claim 2 (depends on 1)

The method of claim 1, wherein amino acids of compound (a) or (b) have either (L) or (D) configurations.

### Claim 3 (depends on 1)

The method of claim 1, wherein the compound is selected from the group consisting of
(a) (L)Lys-(D)Pro-(L)Thr and
(b) (L)pGlu-(L)His-(L)Pro.

### Claim 4 (depends on 1)

The method of claim 1, wherein the compound is chemically modified by alkylation, arylation, etherification, esterification, or combinations thereof.

### Claim 5 (depends on 1)

The method of claim 1, wherein the compound is acetylated at the N-terminus, amidated at the C-terminus, esterified at the C-terminus, or combinations thereof.

### Claim 6 (depends on 1)

The method of claim 1, wherein the compound is (a) NLys-Pro-ThrC.

### Claim 7 (depends on 6)

The method of claim 6, wherein the compound is (a) (L)Lys-(D)Pro-(L)Thr.

### Claim 8 (depends on 1)

The method of claim 1, wherein following the step of applying the skin of the subject is exposed to UV-A-containing sunlight.

### Claim 9 (depends on 1)

The method of claim 1, wherein the composition comprises a cosmetically acceptable carrier or excipient.

### Claim 10 (depends on 9)

The method of claim 9 wherein the carrier or excipient is selected from the group consisting of moisturizing substances, olfactory agents, emulsifiers, and preservatives.

### Claim 11 (depends on 1)

The method of claim 1 wherein the composition comprises one or more UV-filtering substance(s) that can absorb UV radiation in the UV-B region, UV-A region, or both

### Claim 12 (depends on 1)

The method of claim 1 wherein the composition is in form of a lotion, gel, spray, or cream.

### Claim 13 (depends on 1)

The method of claim 1 wherein the composition is in the form of an ointment or cream.

### Claim 14 (depends on 1)

The method of claim 1, wherein the compound is applied to the skin in an amount in the range of about 1 ng to 1 μg per cm2 (compound/skin).

### Claim 15 (depends on 14)

The method of claim 14, wherein the amount is applied per day.

### Claim 16 (depends on 15)

The method of claim 15, wherein the amount in multiple portions per day.

### Claim 17 (depends on 1)

The method of claim 1 wherein the subject has a condition selected from the group consisting of vitiligo, scleroderma, hair loss, premature formation of grey hair, and skin aging.

### Claim 18 (depends on 1)

The method of claim 1 wherein following the step of applying, the subject becomes exposed to light in a UV-A radiation amount of at least 10 J/cm2 of skin.

### Claim 19 (depends on 1)

The method of claim 1 wherein the composition suppresses intracellular amplification of reactive oxygen species (ROS) otherwise increased in response to the UV-A irradiation from light.

### Claim 20 (depends on 1)

The method of claim 1 wherein the composition has no or negligible melanotropic effect.
